Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019
Open Access
- 10 June 2021
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 35 (10) , 5417-5426
Abstract
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first occurred in China in December 2019 and subsequently spread all over the world with cardiovascular, renal, and pulmonary symptoms. Therefore, recognizing and treating the cardiovascular sign and symptoms that caused by coronavirus disease 2019 (COVID-19) can be effective in reducing patient mortality. To control the COVID-19-related cardiovascular symptoms, natural products are considered one of the promising choices as complementary medicine. Scientists are struggling to discover new antiviral agents specific to this virus. In this review, the natural products for management of cardiovascular symptoms of COVID-19 are categorized into three groups: (a) natural products with an impact on angiotensin II type 1 receptor; (b) natural products that inhibit angiotensin-converting enzyme activity; and (c) natural products that mimic adenosine activity. All these natural products should undergo clinical investigations to test their efficacy, safety, and toxicity in the treatment of cardiovascular symptoms of COVID-19. This article summarizes agents with potential efficacy against COVID-19-related cardiovascular symptoms.Keywords
This publication has 62 references indexed in Scilit:
- Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and DiseaseInternational Journal of Peptides, 2012
- Antioxidant activities, sensory and anti-influenza activity of grape skin tea infusionFood Chemistry, 2011
- Cardiovascular friendly natural products: a promising approach in the management of CVDNatural Product Research, 2010
- Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical IndustryMarine Drugs, 2010
- Angiotensin‐converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesionsThe Journal of Pathology, 2008
- The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in miceExperimental Physiology, 2008
- Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin IIHypertension, 2006
- In VitroInhibition of [3 H]-Angiotensin II Binding on the Human AT1Receptor by Proanthocyanidins fromGuazuma ulmifoliaBarkPlanta Medica, 2002
- Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric OxideHypertension, 1996
- 1-Methylisoguanosine: An orally active marine natural product with skeletal muscle and cardiovascular effectsLife Sciences, 1980